Cargando…

New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles

Lipid nanoparticles (liposomes) were first described in 1965, and several work have led to development of important technical advances like triggered release liposomes and drug-loaded liposomes. These advances have led to numerous clinical trials in such diverse areas such as the delivery of anti-ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Beiranvand, Siavash, Eatemadi, Ali, Karimi, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920745/
https://www.ncbi.nlm.nih.gov/pubmed/27342601
http://dx.doi.org/10.1186/s11671-016-1520-8
_version_ 1782439433684910080
author Beiranvand, Siavash
Eatemadi, Ali
Karimi, Arash
author_facet Beiranvand, Siavash
Eatemadi, Ali
Karimi, Arash
author_sort Beiranvand, Siavash
collection PubMed
description Lipid nanoparticles (liposomes) were first described in 1965, and several work have led to development of important technical advances like triggered release liposomes and drug-loaded liposomes. These advances have led to numerous clinical trials in such diverse areas such as the delivery of anti-cancer, antifungal, and antibiotic drugs; the delivery of gene medicines; and most importantly the delivery of anesthesia drugs. Quite a number of liposomes are on the market, and many more are still in developmental stage. Lipid nanoparticles are the first nano-medicine delivery system to be advanced from laboratory concept to clinical application with high considerable clinical acceptance. Drug delivery systems for local anesthetics (LAs) have caught the interest of many researchers because there are many biomedical advantages connected to their application. There have been several formulation techniques to systemically deliver LA that include encapsulation in liposomes and complexation in cyclodextrins, nanoparticles, and to a little extent gold nanoparticles. The proposed formulations help to decrease the LA concentration utilized, increase its permeability, and most importantly increase the localization of the LA for a long period of time thereby leading to increase in the duration of the LA effect and finally to reduce any local and systemic toxicity. In this review, we will highlight on new updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles.
format Online
Article
Text
id pubmed-4920745
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-49207452016-07-06 New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles Beiranvand, Siavash Eatemadi, Ali Karimi, Arash Nanoscale Res Lett Nano Review Lipid nanoparticles (liposomes) were first described in 1965, and several work have led to development of important technical advances like triggered release liposomes and drug-loaded liposomes. These advances have led to numerous clinical trials in such diverse areas such as the delivery of anti-cancer, antifungal, and antibiotic drugs; the delivery of gene medicines; and most importantly the delivery of anesthesia drugs. Quite a number of liposomes are on the market, and many more are still in developmental stage. Lipid nanoparticles are the first nano-medicine delivery system to be advanced from laboratory concept to clinical application with high considerable clinical acceptance. Drug delivery systems for local anesthetics (LAs) have caught the interest of many researchers because there are many biomedical advantages connected to their application. There have been several formulation techniques to systemically deliver LA that include encapsulation in liposomes and complexation in cyclodextrins, nanoparticles, and to a little extent gold nanoparticles. The proposed formulations help to decrease the LA concentration utilized, increase its permeability, and most importantly increase the localization of the LA for a long period of time thereby leading to increase in the duration of the LA effect and finally to reduce any local and systemic toxicity. In this review, we will highlight on new updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles. Springer US 2016-06-24 /pmc/articles/PMC4920745/ /pubmed/27342601 http://dx.doi.org/10.1186/s11671-016-1520-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Nano Review
Beiranvand, Siavash
Eatemadi, Ali
Karimi, Arash
New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles
title New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles
title_full New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles
title_fullStr New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles
title_full_unstemmed New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles
title_short New Updates Pertaining to Drug Delivery of Local Anesthetics in Particular Bupivacaine Using Lipid Nanoparticles
title_sort new updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles
topic Nano Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920745/
https://www.ncbi.nlm.nih.gov/pubmed/27342601
http://dx.doi.org/10.1186/s11671-016-1520-8
work_keys_str_mv AT beiranvandsiavash newupdatespertainingtodrugdeliveryoflocalanestheticsinparticularbupivacaineusinglipidnanoparticles
AT eatemadiali newupdatespertainingtodrugdeliveryoflocalanestheticsinparticularbupivacaineusinglipidnanoparticles
AT karimiarash newupdatespertainingtodrugdeliveryoflocalanestheticsinparticularbupivacaineusinglipidnanoparticles